Biotron Limited (BIT) is a clinical stage publicly listed Australian Biotechnology Company based in Sydney, Australia. The company is developing and commercialising a novel small molecule approach that has the potential to treat a number of serious viral diseases. The technology targets viroporin proteins, which are key to enabling the pathogenicity of a number of viruses including hepatitis C, HIV-1, Dengue, Zika, Influenza and Respiratory Syncytial Virus (RSV).
Find out what a historical investment in Biotron Call 0.02 AUD Biotron 24Nov27 Opt Def would be worth today using our BITO stock calculator.
Buying BITO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Biotron Call 0.02 AUD Biotron 24Nov27 Opt Def in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in BITO
What is the ticker symbol of Biotron Call 0.02 AUD Biotron 24Nov27 Opt Def?
The ticker symbol for Biotron Call 0.02 AUD Biotron 24Nov27 Opt Def is BITO.
How much is one share of BITO?
One share of BITO is valued at $0.00 as of 20 November 2026.
What is the market capitalisation of Biotron Call 0.02 AUD Biotron 24Nov27 Opt Def BITO?
As of 20 November 2026 Biotron Call 0.02 AUD Biotron 24Nov27 Opt Def has a market cap of $4.18M.
What is the P/E ratio of BITO?
The Price to Earnings ratio of BITO is -1.43.
What is the Earnings Per Share of BITO?
The Earnings Per Share of BITO is -$0.00.
What is the 52-week high for Biotron Call 0.02 AUD Biotron 24Nov27 Opt Def stock?
The Biotron Call 0.02 AUD Biotron 24Nov27 Opt Def 52-week high stock price is $0.00.
What is the 52-week low for Biotron Call 0.02 AUD Biotron 24Nov27 Opt Def stock?
The Biotron Call 0.02 AUD Biotron 24Nov27 Opt Def 52-week low stock price is $0.00.
Can I buy BITO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BITO shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.